| Trial ID: | L0753 |
| Source ID: | NCT03914495
|
| Associated Drug: |
Inulin
|
| Title: |
The Role of Microbiome Reprogramming on Liver Fat Accumulation
|
| Acronym: |
MILE
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD
|
| Interventions: |
Dietary Supplement: Inulin;Dietary Supplement: Placebo
|
| Outcome Measures: |
Absolute Change in Liver Fatnan
|
| Sponsor/Collaborators: |
AdventHealth Translational Research Institute
|
| Gender: |
All
|
| Age: |
35 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
40
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).
|
| Start Date: |
11/04/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
31 January 2022
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03914495
|
